88 related articles for article (PubMed ID: 21338280)
1. Overexpression of phosphorylated p27 Kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.
Sirinian C; Symeonidis A; Giannakoulas N; Zolota V; Melachrinou M
Leuk Lymphoma; 2011 May; 52(5):814-22. PubMed ID: 21338280
[TBL] [Abstract][Full Text] [Related]
2. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation.
Hang Q; Fei M; Hou S; Ni Q; Lu C; Zhang G; Gong P; Guan C; Huang X; He S
Med Oncol; 2012 Dec; 29(5):3504-14. PubMed ID: 22492278
[TBL] [Abstract][Full Text] [Related]
3. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS
Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407
[TBL] [Abstract][Full Text] [Related]
4. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.
Sarek G; Järviluoma A; Ojala PM
Blood; 2006 Jan; 107(2):725-32. PubMed ID: 16160006
[TBL] [Abstract][Full Text] [Related]
5. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
6. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.
Martins CP; Berns A
EMBO J; 2002 Jul; 21(14):3739-48. PubMed ID: 12110586
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
8. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
9. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
[TBL] [Abstract][Full Text] [Related]
10. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
11. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.
Dellas A; Jundt G; Sartorius G; Schneider M; Moch H
Clin Cancer Res; 2009 Apr; 15(7):2456-62. PubMed ID: 19293259
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.
Gloghini A; Gaidano G; Larocca LM; Pierconti F; Cingolani A; Dal Maso L; Capello D; Franceschi S; Tirelli U; Libra M; Niu H; Dalla-Favera R; Carbone A
Am J Pathol; 2002 Jul; 161(1):163-71. PubMed ID: 12107101
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
14. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
15. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829
[TBL] [Abstract][Full Text] [Related]
16. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma.
Ferreri AJ; Ponzoni M; Pruneri G; Freschi M; Rossi R; Dell'Oro S; Baldini L; Buffa R; Carboni N; Villa E; Viale G
Int J Cancer; 2001 Nov; 94(4):599-604. PubMed ID: 11745451
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 regulates p27(Kip1) stability in B cells.
Bustany S; Tchakarska G; Sola B
Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of extracellular signal-regulated kinase and p27(KIP1) after retinal detachment.
Kase S; Yoshida K; Harada T; Harada C; Namekata K; Suzuki Y; Ohgami K; Shiratori K; Nakayama KI; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):352-8. PubMed ID: 16075224
[TBL] [Abstract][Full Text] [Related]
20. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
